Suppr超能文献

纤维蛋白溶解系统基因靶向失活小鼠血管损伤后纤溶酶原/纤溶酶和基质金属蛋白酶系统的功能

Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.

作者信息

Lijnen H R, Van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D

机构信息

Center for Molecular and Vascular Biology, University of Leuven, Belgium.

出版信息

Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1035-45. doi: 10.1161/01.atv.18.7.1035.

Abstract

The matrix metalloproteinase (MMP) system, which may be activated via the plasminogen (Plg)/plasmin system, is claimed to play a role in matrix degradation and smooth muscle cell migration. To test the role of both systems, expression of fibrinolytic and gelatinolytic activity was quantified after vascular injury in mice with targeted inactivation of tissue-type Plg activator (tPA-/-), urokinase-type Plg activator (uPA-/-), or Plg (Plg-/-). Neointima formation 1 week after vascular injury was impaired in uPA-/- and Plg-/- mice compared with wild-type (WT) mice or tPA-/- mice (reduction of neointimal area to 30% and 10% of WT, respectively). Cell accumulation at the borders of the injury was significantly (P<0.01) impaired compared with that in WT mice. One week after injury of the femoral artery, tPA-mediated fibrinolytic activity in arterial sections or extracts of WT, uPA-/-, or Plg-/- mice was not altered, whereas uPA activity levels in tPA-/- and Plg-/- mice were 2- to 3-fold higher than in uninjured controls. Total levels (latent plus active) of MMP-2 (gelatinase A) were increased by 2- to 4-fold, whereas the contribution of active MMP-2 represented 38% to 63% of the total in the different genotypes. MMP-9 (gelatinase B) was not detectable in the majority of control arteries, whereas total MMP-9 levels after injury were dramatically increased (up to 50-fold above the detection limit). Active MMP-9 represented 20% to 46% of total MMP-9 in WT, tPA-/-, and uPA-/- mice but was not consistently detectable in Plg-/- mice. Similar results were obtained in carotid arteries. Thus, the unaltered ratios of active and latent MMP-2 suggest that proMMP-2 activation may occur in the absence of tPA, uPA, or Plg, whereas no active MMP-9 was detected in the absence of Plg. The data of this study confirm a role for uPA and Plg but not for tPA in smooth muscle cell migration and neointima formation after vascular injury and indicate that impairment of these phenomena may occur despite the observed increases in MMP-2 or MMP-9 levels after vascular injury.

摘要

基质金属蛋白酶(MMP)系统可能通过纤溶酶原(Plg)/纤溶酶系统被激活,据称其在基质降解和平滑肌细胞迁移中发挥作用。为了测试这两个系统的作用,在组织型Plg激活剂(tPA-/-)、尿激酶型Plg激活剂(uPA-/-)或Plg(Plg-/-)靶向失活的小鼠血管损伤后,对纤溶和明胶溶解活性的表达进行了定量。与野生型(WT)小鼠或tPA-/-小鼠相比,uPA-/-和Plg-/-小鼠血管损伤1周后的新生内膜形成受损(新生内膜面积分别降至WT的30%和10%)。与WT小鼠相比,损伤边界处的细胞积聚明显(P<0.01)受损。股动脉损伤1周后,WT、uPA-/-或Plg-/-小鼠动脉切片或提取物中tPA介导的纤溶活性未改变,而tPA-/-和Plg-/-小鼠中的uPA活性水平比未受伤对照高2至3倍。MMP-2(明胶酶A)的总水平(潜伏加活性)增加了2至4倍,而活性MMP-2在不同基因型中的占比为总水平的38%至63%。在大多数对照动脉中未检测到MMP-9(明胶酶B),而损伤后MMP-9的总水平显著增加(高达检测限以上50倍)。在WT、tPA-/-和uPA-/-小鼠中,活性MMP-9占MMP-9总量的20%至46%,但在Plg-/-小鼠中未始终检测到。在颈动脉中也获得了类似结果。因此,活性和潜伏MMP-2的比例未改变表明,在没有tPA、uPA或Plg的情况下,proMMP-2可能被激活,而在没有Plg的情况下未检测到活性MMP-9。本研究数据证实了uPA和Plg在血管损伤后平滑肌细胞迁移和新生内膜形成中的作用,但tPA无此作用,并表明尽管观察到血管损伤后MMP-2或MMP-9水平升高,这些现象仍可能受损。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验